Skip to content

An etiopathological study of palmoplantar psoriasis

An Etiopathological Study of Vipadika Kustha and Comparative Therapeutic Trial of Sarjarasa Lepa And Dhaturbeej Taila.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052620
Enrollment
60
Registered
2023-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

National institute of Ayurveda deemed to be university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient with the classical sign and symptoms of Vipadika Kustha 2) Patients will be selected irrespective of sex, caste, occupation, socio-economic status. 3) Patients in detail. willing to participate in the study will be selected by explaining the interventions 4)Patient willing to give written informed consent. 5) Patient willing to follow up.

Exclusion criteria

Exclusion criteria: 1. The patient suffering from malignant systemic disorders, especially those are mentioned as Asadhya Vyadhi as per clinical text of Ayurveda will be excluded. 2. Patient with history of psoriasis. 3. Patient on some other medication. 4. Patient with other systemic disorders like DM etc. 5. Patient under other treatments of Vipadika

Design outcomes

Primary

MeasureTime frame
1) To compare the efficacy of Sarjarasa Lepa and Dhaturbeej Taila in the Management of Vipadika in terms of change in Ayurvedic Symptom Score before and after intervention Le. between day 0 and Day 30Timepoint: 2 month

Secondary

MeasureTime frame
1) To study the etiopathogenesis of Vipadika Kustha 2) To evaluate the efficacy of Dhaturbeej taila in the management of Vipadika. 3) To evaluate the efficacy of Sarjarasa Lepa in the management of Vipadika. 4) To assess the change in Dermatology Life Quality Index (DLQI) (Appendix 1) before and after intervention i.e. b/w day 0 and day 30Timepoint: 2 month

Countries

India

Contacts

Public ContactManisha Meena

National institute of Ayurveda Jaipur

drbks6@gmail.com9352311105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026